SCHEMBL6946233

SCHEMBL6946233

CCc1c(O)cccc1C(N)=O

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.55
ALDH1A1 P00352 4/20 0.55
MAPT P10636 3/20 0.55
HPGD P15428 3/20 0.55
HSD17B10 Q99714 3/20 0.55
TSHR P16473 2/20 0.55
PARP1 P09874 4/20 0.46
G6PD P11413 1/20 0.41
CASP7 P55210 1/20 0.41
CASP6 P55212 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
HTT P42858 3/20 0.41
CA12 O43570 1/20 0.40
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40
CA7 P43166 1/20 0.40
CA9 Q16790 1/20 0.40
CA14 Q9ULX7 1/20 0.40
AKR1C3 P42330 1/20 0.40
AKR1C2 P52895 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL45719 0.88 PARP1 (0.51) KDM4EALDH1A1MAPTHPGDHSD17B10
SCHEMBL72113 0.84 PARP1 (0.49) KDM4EALDH1A1MAPTHPGDHSD17B10
SCHEMBL8878159 0.83 KDM4E (0.57) KDM4EALDH1A1MAPTHPGDHSD17B10
SCHEMBL11221608 0.83 KDM4E (0.52) KDM4EALDH1A1MAPTHPGDHSD17B10
SCHEMBL6321332 0.82 PARP1 (0.47) KDM4EALDH1A1MAPTHPGDHSD17B10
Fluoride SCHEMBL28693457 0.82 PARP1 (0.47) KDM4EALDH1A1MAPTHPGDHSD17B10
SCHEMBL1242279 0.82 ALDH1A1 (0.54) KDM4EALDH1A1HPGDHSD17B10TSHR
Hydrochloric Acid SCHEMBL7467552 0.82 PARP1 (0.47) KDM4EALDH1A1MAPTHPGDHSD17B10
Charcoal, Activated SCHEMBL9345241 0.82 PARP1 (0.47) KDM4EALDH1A1MAPTHPGDHSD17B10
Hydrochloric Acid SCHEMBL8527465 0.82 PARP1 (0.47) KDM4EALDH1A1MAPTHPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0996446-B1 NOVEL SUBSTITUTED IMIDAZOLE COMPOUNDS SMITHKLINE BEECHAM CORP (US) 2003-09-17 EP disclosed
US-6562832-B1 Cytokine suppressive anti-inflammatory drugs, capable of inhibiting the CSBP/p38/RK kinase SMITHKLINE BEECHAM CORPORATION 2003-05-13 US disclosed
EP-0996446-A4 NOVEL SUBSTITUTED IMIDAZOLE COMPOUNDS SMITHKLINE BEECHAM CORP (US) 2001-08-29 EP disclosed
EP-0996446-A1 NOVEL SUBSTITUTED IMIDAZOLE COMPOUNDS SMITHKLINE BEECHAM CORPORATION (US) 2000-05-03 EP disclosed
US-6046208-A TREATMENT OF RHEUMATOID ARTHRITIS, OSTEOARTHRITIS, ENDOTOXEMIA AND/OR TOXIC SHOCK SYNDROME, OTHER ACUTE OR CHRONIC INFLAMMATORY DISEASE STATES SUCH AS THE INFLAMMATORY REACTION INDUCED BY ENDOTOXIN OR INFLAMMATORY BOWEL DISEASE SMITHKLINE BEECHAM CORPORATION (US) 2000-04-04 US disclosed
WO-1999001131-A1 NOVEL SUBSTITUTED IMIDAZOLE COMPOUNDS SMITHKLINE BEECHAM CORPORATION (US) 1999-01-14 WO disclosed